The way high blood pressure is treated could soon witness its biggest shift in decades, with long-acting injectable therapies promising control with just two doses a year instead of daily pills. A ...
The "silent killer" may finally meet a powerful new shield marking a seismic shift in cardiology —one injection that protects for six months at a time.
In men with type 2 diabetes, higher baseline testosterone may reduce risk for cardiovascular events, whereas greater change in estradiol after weight loss may raise CV risk.However, there was no ...